Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TAKAMISAWA, First Half Ordinary Profit Decreases by 28%, Oct-Dec Ordinary Profit Decreases by 17%
5283 TAKAMISAWA CO., LTD. 【J-GAAP】
Earnings ReportTAKAMISAWA CO., LTD. <5283> [TSE Std] announced its financial results after the market closed on February 6th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending June 2026 (July to December) decreased 28.1% from the same period last year to 0.80 billion yen. Progress toward the full-year plan of 1.80 billion yen was 44.8%, also falling below the five-year average of 59.5%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to June period (second half) is expected to expand 81.1% from the same period last year, reaching 0.99 billion yen.
In the most recent three-month period, from October to December (2Q), the consolidated ordinary profit decreased to 0.65 billion yen, a 17.0% decrease compared to the same period last year. The operating profit margin worsened from 3.3% in the same period last year to 2.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2023 | 36,296 | 977 | 1,101 | 743 | 443.8 | 52.1 | Feb 9, 2024 | J-GAAP |
| Jul - Dec, 2024 | 37,574 | 913 | 1,121 | 752 | 450.9 | 67.1 | Feb 7, 2025 | J-GAAP |
| Jul - Dec, 2025 | 37,967 | 716 | 806 | 704 | 426.4 | 44.8 | Feb 6, 2026 | J-GAAP |
| YoY | +1.0% | -21.6% | -28.1% | -6.4% | -5.4% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2025 Guidance | ー | ー | ー | ー | - | 0 | Aug 8, 2025 | J-GAAP |
| Jul - Dec, 2025 Results | 37,967 | 716 | 806 | 704 | 426.4 | 0 | Feb 6, 2026 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 35,993 | 544 | 549 | -82 | -49.2 | 50 | Aug 8, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | 36,033 | 884 | 994 | 296 | 179.2 | 70 | Feb 6, 2026 | J-GAAP |
| YoY | +0.1% | +62.5% | +81.1% | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2024 | 71,369 | 1,803 | 2,113 | 759 | 454.0 | 50 | Aug 9, 2024 | J-GAAP |
| Jun, 2025 | 73,567 | 1,457 | 1,670 | 670 | 402.4 | 50 | Aug 8, 2025 | J-GAAP |
| Jun, 2026 Guidance | 74,000 | 1,600 | 1,800 | 1,000 | 605.3 | 70 | Aug 8, 2025 | J-GAAP |
| YoY | +0.6% | +9.8% | +7.8% | +49.3% | +50.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 20,601 | 682 | 788 | 534 | 320.2 | 3.3 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 18,804 | 460 | 403 | 259 | 155.2 | 2.4 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 17,189 | 84 | 146 | -341 | -204.8 | 0.5 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 17,242 | 125 | 152 | 80 | 48.5 | 0.7 | Nov 7, 2025 | J-GAAP |
| Oct - Dec, 2025 | 20,725 | 591 | 654 | 624 | 377.9 | 2.9 | Feb 6, 2026 | J-GAAP |
| YoY | +0.6% | -13.3% | -17.0% | +16.9% | +18.0% |
Related Articles
Yushiro Chemical, Oct-Dec (3Q) Ordinary Profit Increases by 3%
SHOEI YAKUHIN, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 14%
IDEC, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.1 times, Oct-Dec Ordinary Profit Increases by 2.2 times
J-OIL MILLS, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 52%, Oct-Dec Ordinary Profit Decreases by 55%
NICHICON, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 13%
SAPPORO CLINICAL LAB, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Decreases by 9%
SEKI, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 42%
CL Holdings, Net Income Forecast for Last Fiscal Year Revised Upward by 12%, Dividend Revised Upward by 2 Yen
MT GENEX, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 25%, Oct-Dec Ordinary Profit Increases by 93%
Paraca, Oct-Dec (1Q) Ordinary Profit Decreases by 1%